Gene Symbol | KDM8 |
---|---|
Entrez Gene | 79831 |
Alt Symbol | JMJD5 |
Species | Human |
Gene Type | protein-coding |
Description | lysine (K)-specific demethylase 8 |
Other Description | jmjC domain-containing protein 5|jumonji domain containing 5|jumonji domain-containing protein 5|lysine-specific demethylase 8 |
Swissprots | Q9H8B1 B4DLU9 Q8N371 Q6VAK5 |
Accessions | EAW55759 Q8N371 AK023860 BAB14706 AK225066 AK297166 BAG59661 AK298410 BAG60638 AK308499 AK310885 AY345239 AAQ23080 BC027911 AAH27911 BQ022832 DA497245 JF432533 ADZ15750 XM_006721092 XP_006721155 XM_011545950 XP_011544252 XM_011545951 XP_011544253 NM_001145348 NP_001138820 NM_024773 NP_079049 |
Function | Histone demethylase required for G2/M phase cell cycle progression. Specifically demethylates dimethylated 'Lys-36' (H3K36me2) of histone H3, an epigenetic repressive mark, thereby acting as a transcription activator. Regulates expression of CCNA1 (cyclin-A1), leading to regulate cancer cell proliferation. {ECO:0000269|PubMed:20457893}. |
Subcellular Location | Nucleus {ECO:0000269|PubMed:20457893}. |
Tissue Specificity | Weakly expressed in most cells. Highly expressed in breast cancer cells. {ECO:0000269|PubMed:20457893}. |
Human JMJD5 full length protein - ab132413 from Abcam
|
||||||||||
Human JMJD5 peptide - ab36103 from Abcam
|
||||||||||
KDM8 / JMJD5 / FLJ13798 Antibody Blocking Peptide - LS-E646 from LifeSpan Bioscience
|
||||||||||
KDM8 / JMJD5 / FLJ13798 Antibody Blocking Peptide - LS-E30769 from LifeSpan Bioscience
|
||||||||||
KDM8 / JMJD5 / FLJ13798 Antibody Blocking Peptide - LS-E11877 from LifeSpan Bioscience
|
||||||||||
KDM8 / JMJD5 / FLJ13798 Antibody Blocking Peptide - LS-E21265 from LifeSpan Bioscience
|
||||||||||
JMJD5 Recombinant Protein - H00079831-P01 from Novus Biologicals
|
||||||||||
JMJD5 Blocking Peptide - NBP1-77074PEP from Novus Biologicals
|
||||||||||
JMJD5-Antibody-N-term-Blocking-peptide - BP10986a from Abgent, a WuXi AppTec company
|
||||||||||
JMJD5 Peptide - GTX85251-PEP from GeneTex
|
||||||||||
JMJD5 Blocking Peptide - 33R-1191 from Fitzgerald
|
||||||||||
JMJD5 Blocking Peptide - 33R-4751 from Fitzgerald
|
||||||||||
JMJD5 - H00079831-P01-10 from Acris Antibodies
|
||||||||||
JMJD5 - H00079831-P01-25 from Acris Antibodies
|
||||||||||
JMJD5 Control Peptide - AP30463CP-N from Acris Antibodies
|
||||||||||
JMJD5 Peptide - 5381P from ProSci
|
||||||||||
JMJD5 fusion protein - ag15115 from Proteintech Group
|
||||||||||
JMJD5 fusion protein - ag15256 from Proteintech Group
|
||||||||||
Recombinant Human JMJD5, GST-tagged - JMJD5-206H from Creative Biomart
|
||||||||||
Recombinant Human Lysine-specific demethylase 8(JMJD5) - CSB-YP839789HU CSB-EP839789HU CSB-BP839789HU CSB-MP839789HU from Cusabio
|
||||||||||
JMJD5 (transcript variant 2) - TP306417 from Acris Antibodies
|
||||||||||
JMJD5 (transcript variant 1) - TP327709 from Acris Antibodies
|
||||||||||
JMJD5 Protein - NBP1-82249PEP from Novus Biologicals
|
||||||||||
JMJD5-Antibody-C-term-2-Blocking-Peptide - BP1031a from Abgent, a WuXi AppTec company
|
||||||||||
JMJD5-Blocking-Peptide-C-term - BP1031b from Abgent, a WuXi AppTec company
|